Javier Velasco, Silvia González. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAntiviral Agents/adverse effectsAntiviral Agents/therapeutic useCytokines/biosynthesisHepatitis C, Chronic/complicationsHepatitis C, Chronic/drug therapyHumansImmunocompromised HostInterferon-alpha/adverse effectsInterferon-alpha/therapeutic useLatent Tuberculosis/complicationsMaleMycobacterium tuberculosis/growth & developmentMycobacterium tuberculosis/physiologyOpportunistic Infections/etiologyPakistan/epidemiologyPolyethylene Glycols/adverse effectsPolyethylene Glycols/therapeutic useRecombinant Proteins/adverse effectsRecombinant Proteins/therapeutic useRibavirin/administration & dosageRibavirin/therapeutic useTuberculosis, Lymph Node/etiology
Substances： See more » Antiviral AgentsCytokinesInterferon-alphaRecombinant ProteinsPolyethylene GlycolsRibavirinpeginterferon alfa-2a
Year: 2011 PMID： 21570741 DOI： 10.1016/j.eimc.2011.03.009
Source DB: PubMed Journal: Enferm Infecc Microbiol Clin ISSN： 0213-005X Impact factor: 1.731